Investigational Drug Information for Manogepix
✉ Email this page to a colleague
What is the development status for investigational drug Manogepix?
Manogepix is an investigational drug.
There have been 6 clinical trials for Manogepix.
The most recent clinical trial was a Phase 1 trial, which was initiated on December 5th 2022.
The most common disease conditions in clinical trials are Mycoses, Candidemia, and Candidiasis, Invasive. The leading clinical trial sponsors are Pfizer, Amplyx Pharmaceuticals, and [disabled in preview].
There is one US patent protecting this investigational drug and thirty-three international patents.
Summary for Manogepix
| US Patents | 1 |
| International Patents | 33 |
| US Patent Applications | 28 |
| WIPO Patent Applications | 10 |
| Japanese Patent Applications | 5 |
| Clinical Trial Progress | Phase 1 (2022-12-05) |
| Vendors | 34 |
Recent Clinical Trials for Manogepix
| Title | Sponsor | Phase |
|---|---|---|
| A Study to Learn About the Study Medicine (Called Fosmanogepix/ PF-07842805) in People With Candidemia and/or Invasive Candidiasis. | Pfizer | Phase 3 |
| A Clinical Trial of the Study Medicine (Called Fosmanogepix) in People With Hepatic Dysfunction. | Pfizer | Phase 1 |
| A Bioequivalence Study of APX001 High-load and Low-load Tablets | Pfizer | Phase 1 |
Clinical Trial Summary for Manogepix
Top disease conditions for Manogepix
Top clinical trial sponsors for Manogepix
US Patents for Manogepix
International Patents for Manogepix
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Manogepix | Australia | AU2008246798 | 2027-04-27 | ⤷ Sign Up |
| Manogepix | Canada | CA2685194 | 2027-04-27 | ⤷ Sign Up |
| Manogepix | China | CN101622251 | 2027-04-27 | ⤷ Sign Up |
| Manogepix | China | CN102702185 | 2027-04-27 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
